⌘K
Loading ticker…
As of 2026-08-21, Aura Biosciences, Inc. Common Stock (AURA) has a 3-month relative strength percentile of 52 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.6%, relative volume 0.68×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AURA is in a stage 2 uptrend, week 5. Currently in a 75-day base; basing ADR 5.7% (broad 6.2%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 9.2% / 20.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
AURA is held by 16 ETFs as of May 2026. Top owner: VHT at 0.01% weight, $2M notional. Top 3 carry $4M.
Held by 33 ETFs · $34M across latest filings · largest weight 0.64% (EVNT).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.01% | $2M | — |
| VTWO | 0.01% | $2M | — |
| AVSC | 0.01% | $278K | — |
| VTWV | 0.01% | $186K | — |
| VTWG | 0.01% | $104K | — |
| EVNT | 0.64% | $78K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $28K | — |
| IBBQ | 0.04% | $25K | — |
| BIB | 0.02% | $18K | — |
| OMFS | 0.01% | $16K | new |
Showing 10 of 16 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AURA Jan avg: -3.92% median: -2.68% win: 25% σ: 6.79% n: 4 2022-04-12 → 2026-07-31 | AURA Feb avg: 3.59% median: 0.57% win: 50% σ: 10.47% n: 4 2022-04-12 → 2026-07-31 | AURA Mar avg: -7.18% median: -10.28% win: 25% σ: 15.09% n: 4 2022-04-12 → 2026-07-31 | AURA Apr avg: -0.85% median: -0.82% win: 20% σ: 4.06% n: 5 2022-04-12 → 2026-07-31 | AURA May avg: 6.80% median: 3.01% win: 80% σ: 10.61% n: 5 2022-04-12 → 2026-07-31 | AURA Jun avg: -1.01% median: 2.86% win: 60% σ: 11.33% n: 5 2022-04-12 → 2026-07-31 | AURA Jul avg: 8.17% median: 0.64% win: 60% σ: 15.90% n: 5 2022-04-12 → 2026-07-31 | AURA Aug avg: -12.59% median: -10.96% win: 0% σ: 6.89% n: 4 2022-04-12 → 2026-07-31 (current) | AURA Sep avg: 8.21% median: 5.40% win: 50% σ: 21.07% n: 4 2022-04-12 → 2026-07-31 | AURA Oct avg: -6.07% median: -4.92% win: 25% σ: 20.24% n: 4 2022-04-12 → 2026-07-31 | AURA Nov avg: 2.60% median: 2.98% win: 50% σ: 11.32% n: 4 2022-04-12 → 2026-07-31 | AURA Dec avg: -11.28% median: -14.57% win: 25% σ: 15.73% n: 4 2022-04-12 → 2026-07-31 |